Literature DB >> 28601389

Effects of lentivirus-mediated silencing of Periostin on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer.

Jing Che1, Wen-Zhuang Shen2, Yu Deng3, Yu-Hong Dai4, Yong-De Liao3, Xiang-Lin Yuan4, Peng Zhang5.   

Abstract

The study aims to investigate the effects of Periostin gene silencing on tumor microenvironment and bone metastasis via the integrin-signaling pathway in lung cancer (LC). LC patients were divided into bone metastasis and non-bone metastasis groups; Healthy volunteers were selected as normal group. ELISA was performed to detect serum Periostin levels and plasma calcium ion concentration. SBC-5 cells were assigned into blank group (without transfection), negative control (NC) group (transfected with empty plasmid), si-Periostin group (transfected with si-Periostin plasmid), si-Integrin-αvβ3 group (transfected with Integrin-αvβ3 siRNA plasmid) and si-Periostin+si-Integrin-αvβ3 group (transfected with si-Periostin and si-Integrin-αvβ3 plasmid). qRT-PCR and Western blotting were performed to determine mRNA and protein expression of Periostin, metastasis-associated factors of tumor microenvironment and integrin signaling pathway-related proteins. CCK-8, scratch test and transwell assay were applied to detect cell proliferation, migration and invasion respectively. Nude mouse models of LC bone metastasis were established. TRAP Staining was employed to measure the number of osteoclasts. Bone metastasis group exhibited higher levels of Periostin compared to normal and non-bone metastasis groups. Si-Periostin, si-Integrin-αvβ3 and si-Periostin+si-Integrin-αvβ3 groups showed decreased Periostin expression, proliferation rate, migration distance, invasive cells, and expressions of metastasis-associated factors of tumor microenvironment and integrin signaling pathway-related proteins compared to blank and NC groups. Similarly, number of osteoclasts and expression of integrin signaling pathway-related proteins were decreased, and bone injury and calcium ion concentration were reduced. The study demonstrated that down-regulation of Periostin expression modulated tumor microenvironment and inhibited bone metastasis by blocking integrin-signaling pathway in LC.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone metastasis; Integrin; Lung cancer; Periostin; Signaling pathway; Tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28601389     DOI: 10.1016/j.lfs.2017.05.030

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Diagnostic value of periostin in lung cancer-related malignant pleural effusion.

Authors:  Jinjin Zhang; Tongtong Zha; Na Zhang; Gengyun Sun
Journal:  J Clin Lab Anal       Date:  2021-12-27       Impact factor: 2.352

Review 2.  Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression.

Authors:  Laura González-González; Javier Alonso
Journal:  Front Oncol       Date:  2018-06-12       Impact factor: 6.244

3.  Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.

Authors:  Khine Kyaw Oo; Thanpawee Kamolhan; Anish Soni; Suyanee Thongchot; Chalermchai Mitrpant; Pornchai O-Charoenrat; Chanitra Thuwajit; Peti Thuwajit
Journal:  BMC Cancer       Date:  2021-01-14       Impact factor: 4.430

4.  Tumor- and Osteoblast-Derived Periostin in Prostate Cancer bone Metastases.

Authors:  Chuan-Yu Sun; Yuan-Yuan Mi; Sheng-Yang Ge; Qing-Feng Hu; Ke Xu; Yi-Jun Guo; Yi-Fan Tan; Yang Zhang; Fan Zhong; Guo-Wei Xia
Journal:  Front Oncol       Date:  2022-01-11       Impact factor: 6.244

5.  Role of Periostin Expression in Non-Small Cell Lung Cancer: Periostin Silencing Inhibits the Migration and Invasion of Lung Cancer Cells via Regulation of MMP-2 Expression.

Authors:  Katarzyna Ratajczak-Wielgomas; Alicja Kmiecik; Piotr Dziegiel
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

6.  Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma.

Authors:  E Massy; J C Rousseau; M Gueye; E Bonnelye; M Brevet; L Chambard; M Duruisseaux; O Borel; C Roger; R Guelminger; J B Pialat; E Gineyts; L Bouazza; M Millet; J M Maury; P Clézardin; N Girard; Cyrille B Confavreux
Journal:  J Bone Oncol       Date:  2021-06-05       Impact factor: 4.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.